首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Journal of chemotherapy

缩写:J CHEMOTHERAPY

ISSN:1120-009X

e-ISSN:1973-9478

IF/分区:1.8/Q3

文章目录 更多期刊信息

共收录本刊相关文章索引1586
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Şerife Çevik,Selma Gökahmetoğlu,Ömür Mustafa Parkan et al. Şerife Çevik et al.
This study investigated antiviral resistance by sequencing UL97 and UL54 in cytomegalovirus (CMV) strains from haematology and hematopoietic stem cell transplant (HSCT) patients. Fifty-one samples from 48 patients (21 paediatric and 27 adul...
Demet Isik Bayraktar,Recep Turkel,Guzin Demirag Demet Isik Bayraktar
Anthracyclines are essential agents in the treatment of breast cancer. This study investigated the effect of anthracyclines on arteriosclerosis. The study group consisted of 60 patients not receiving anticoagulants and was divided into two ...
Yi Huang,Lijuan Feng,Jing Hu et al. Yi Huang et al.
This study aimed to investigate the short-term trajectory of peripheral neuropathy in patients receiving triweekly albumin-bound paclitaxel (nab-paclitaxel) chemotherapy. 235 patients were recruited from March to August 2024, of whom 65.1% ...
Zi Wang,Yan Zhang,Danqing Zhao et al. Zi Wang et al.
This study investigated the risk factors associated with infusion-related reactions (IRRs) in B-cell lymphoma patients receiving obinutuzumab. A retrospective analysis of Peking Union Medical College Hospital patients (January 2021-December...
Héctor Carlos García-Díaz,Javier Gómez-Alonso,María Teresa Rabuñal-Álvarez et al. Héctor Carlos García-Díaz et al.
Patients with pancreatic cancer (PC) harboring DNA damage repair genes (DDRg) alterations, particularly BRCA1/2, may benefit from olaparib. Although the phase III POLO trial demonstrated improved progression-free survival (PFS) with olapari...
Diego A Hernandez,Gabriela Petersen,Jimena Gonzalez-Salido et al. Diego A Hernandez et al.
Lung cancer remains the leading cause of cancer-related mortality worldwide. Among patients with advanced non-small cell lung cancer (NSCLC), ALK-positive disease accounts for roughly 5% of cases We conducted a systematic search of PubMed, ...
Klaus-Peter Dieckmann,Markus Angerer,Bernd Eckert et al. Klaus-Peter Dieckmann et al.
Cerebral stroke secondary to cisplatin-based chemotherapy in young patients undergoing chemotherapy for testicular germ cell tumour (GCT) has been reported only sporadically. Here, we report a 49-year-old man undergoing adjuvant chemotherap...
Stefano Fucina,Riccardo Vida,Arianna Dri et al. Stefano Fucina et al.
Ovarian cancer is characterised by a high mortality rate. Standard of care treatment is based on upfront debulking surgery followed by platinum-based chemotherapy. Currently, the majority of patients in response to platinum agents could ben...
I Gusti Ngurah Agung Wiwekananda,Nik Ahmad Nizam Nik Malek,Agustina Tri Endharti et al. I Gusti Ngurah Agung Wiwekananda et al.
Cervical cancer remains a major global health burden, particularly in advanced and recurrent disease, where therapeutic options are limited. We conducted a systematic review of clinical studies evaluating nab-paclitaxel-based regimens in ce...
Yuhui Li,Zheng Shi,Xiaoshuang Fu et al. Yuhui Li et al.
Vinorelbine is widely used for non-small cell lung cancer, breast cancer, and other solid tumors, yet real-world safety data remain limited. We analyzed adverse events associated with vinorelbine using the FDA Adverse Event Reporting System...